Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKD 8.42
(0.0%)
HKD 8.42
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.01 Billion HKD | 115.34% |
| 2022 | 469.78 Million HKD | 8.78% |
| 2021 | 431.86 Million HKD | -12.82% |
| 2020 | 495.37 Million HKD | 55.69% |
| 2019 | 318.18 Million HKD | 30.12% |
| 2018 | 244.53 Million HKD | 3.82% |
| 2017 | 235.53 Million HKD | 31.92% |
| 2016 | 178.53 Million HKD | 11.41% |
| 2015 | 160.25 Million HKD | 32.42% |
| 2014 | 121.02 Million HKD | 18.47% |
| 2013 | 102.15 Million HKD | 27.84% |
| 2012 | 79.9 Million HKD | 41.92% |
| 2011 | 56.3 Million HKD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.6 Billion HKD | 0.0% |
| 2024 Q1 | 1.6 Billion HKD | 58.34% |
| 2023 Q2 | 562.99 Million HKD | 0.0% |
| 2023 FY | 1.01 Billion HKD | 115.34% |
| 2023 Q1 | 562.99 Million HKD | 19.84% |
| 2023 Q4 | 1.01 Billion HKD | 0.0% |
| 2023 Q3 | 1.01 Billion HKD | 79.69% |
| 2022 Q1 | 445.88 Million HKD | 3.25% |
| 2022 FY | 469.78 Million HKD | 8.78% |
| 2022 Q4 | 469.78 Million HKD | 0.0% |
| 2022 Q3 | 469.78 Million HKD | 5.36% |
| 2022 Q2 | 445.88 Million HKD | 0.0% |
| 2021 Q1 | 476.41 Million HKD | -3.83% |
| 2021 FY | 431.86 Million HKD | -12.82% |
| 2021 Q3 | 431.86 Million HKD | -9.35% |
| 2021 Q4 | 431.86 Million HKD | 0.0% |
| 2021 Q2 | 476.41 Million HKD | 0.0% |
| 2020 Q3 | 495.37 Million HKD | 9.16% |
| 2020 FY | 495.37 Million HKD | 55.69% |
| 2020 Q1 | 453.8 Million HKD | 42.62% |
| 2020 Q2 | 453.8 Million HKD | 0.0% |
| 2020 Q4 | 495.37 Million HKD | 0.0% |
| 2019 Q4 | 318.18 Million HKD | 0.0% |
| 2019 Q2 | 268.46 Million HKD | 0.0% |
| 2019 FY | 318.18 Million HKD | 30.12% |
| 2019 Q3 | 318.18 Million HKD | 18.52% |
| 2019 Q1 | 268.46 Million HKD | 9.79% |
| 2018 FY | 244.53 Million HKD | 3.82% |
| 2018 Q4 | 244.53 Million HKD | 0.0% |
| 2018 Q3 | 244.53 Million HKD | -15.24% |
| 2018 Q2 | 288.5 Million HKD | 0.0% |
| 2018 Q1 | - HKD | -100.0% |
| 2017 Q2 | 240.01 Million HKD | 0.0% |
| 2017 FY | 235.53 Million HKD | 31.92% |
| 2017 Q4 | 235.53 Million HKD | 0.0% |
| 2017 Q1 | - HKD | -100.0% |
| 2017 Q3 | - HKD | -100.0% |
| 2016 Q1 | - HKD | -100.0% |
| 2016 FY | 178.53 Million HKD | 11.41% |
| 2016 Q4 | 178.53 Million HKD | 0.0% |
| 2016 Q2 | 163.18 Million HKD | 0.0% |
| 2015 Q4 | 160.25 Million HKD | 0.0% |
| 2015 Q2 | 140.43 Million HKD | 0.0% |
| 2015 FY | 160.25 Million HKD | 32.42% |
| 2015 Q1 | - HKD | -100.0% |
| 2014 FY | 121.02 Million HKD | 18.47% |
| 2014 Q4 | 121.02 Million HKD | 0.0% |
| 2014 Q2 | 100.28 Million HKD | 0.0% |
| 2014 Q1 | - HKD | -100.0% |
| 2013 Q4 | 102.15 Million HKD | 0.0% |
| 2013 Q2 | 73.34 Million HKD | 0.0% |
| 2013 Q1 | - HKD | -100.0% |
| 2013 FY | 102.15 Million HKD | 27.84% |
| 2012 Q4 | 79.9 Million HKD | 0.0% |
| 2012 FY | 79.9 Million HKD | 41.92% |
| 2011 FY | 56.3 Million HKD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| China Healthwise Holdings Limited | 56.02 Million HKD | -1705.774% |
| Tycoon Group Holdings Limited | 141.34 Million HKD | -615.73% |